Technology area: Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Reshape Lifesciences Inc. has 4 pending office actions in Medical Devices & Mechanical Engineering. The matters involve 4 distinct examiners and 3 distinct art units, indicating some art-unit overlap but no repeated examiner assignment.
COLLARD JR, DWANE EDWARD is the busiest examiner, with 1 pending matter. Art-unit-level review may help align positions on device claims, while each matter still calls for a separate examiner-specific response strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COLLARD JR, DWANE EDWARD | 1 | 0.0% | +0.0% |
| TEHRANI, DANIEL | 1 | 60.9% | +41.9% |
| SEVERSON, RYAN J | 1 | 83.1% | +13.4% |
| SCHMITT, BENJAMIN ALLYN | 1 | 12.0% | +35.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18818056 | INTRAGASTRIC DEVICE | SEVERSON, RYAN J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19066714 | SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODS | COLLARD JR, DWANE EDWARD | — |
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | TEHRANI, DANIEL | — |
| 17604309 | METHODS AND SYSTEMS FOR NEURAL REGULATION | SCHMITT, BENJAMIN ALLYN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | TEHRANI, DANIEL | — |
| 18818056 | INTRAGASTRIC DEVICE | SEVERSON, RYAN J | — |
| 17604309 | METHODS AND SYSTEMS FOR NEURAL REGULATION | SCHMITT, BENJAMIN ALLYN | — |
| Art Unit | Apps |
|---|---|
| 3792 | 2 |
| 3771 | 1 |
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19066714 | SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODS | COLLARD JR, DWANE EDWARD | 3792 | §102§103§112 | Non-Final OA | — | Pending | Feb 28, 2025 |
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | TEHRANI, DANIEL | 3792 | §102§103 | Final Rejection | — | Pending | Dec 20, 2024 |
| 18818056 | INTRAGASTRIC DEVICE | SEVERSON, RYAN J | 3771 | §112Other | Non-Final OA | — | Pending | Aug 28, 2024 |
| 17604309 | METHODS AND SYSTEMS FOR NEURAL REGULATION | SCHMITT, BENJAMIN ALLYN | 3796 | §103 | Final Rejection | — | Pending | Oct 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialReshape Lifesciences Inc. has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Dwane Edward Collard Jr. has the most, with 1 of Reshape Lifesciences Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
